We develop global value propositions by conducting payer research, gap analyses, and targeted literature reviews, while aligning with internal teams to create evidence generation plans that optimize market access.
We are technically astute, with experts who bring deep healthcare strategy and clinical knowledge to every project.
Targeted literature review
We review competitor trials, previous HTA submissions, and analogue products.
Gap analysis
We assess the evidence base and identify gaps based on evidentiary requirements for access in the therapeutic area.
Primary research
We recruit 18 payers across the US, UK, Germany, Spain, Italy, and France to validate the value proposition and evidence plan.
Practical Agility
We are practically agile, operating with a lean structure that allows seamless teamwork and swift resource deployment, ensuring efficient project completion without unnecessary bureaucracy.
Internal interviews
We lead internal discussions with client teams across R&D, pricing, medical affairs, and HEOR to align on project goals and evidence requirements.
Key value message testing
We solicit insights from payers on specific evidence requirements from clinical and economic perspectives in a competitive environment.
Payer insights and objection handler
We gather and collate comprehensive views on payer perceptions, opportunities, objections, and barriers to market access.
Evidence generation plan
We develop a well-structured evidence generation plan targeting optimal market access in each country in scope.
FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”
Senior Market Access Manager, Mid-sized Pharma
It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”
Associate Director, Mid-sized Pharma
FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”
Market Access Director, Small Biotech
FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”
Disease Area Director, Big Pharma
The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”
Executive Director, Biotech
FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”
Value Demonstration & Access Lead, Big Pharma
It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”
Senior Vice President, Small Biotech
FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
